Schüler A, Weber S, Neuhäuser M, Jurklies C, Lehnert T, Heimann H, Rudolph G, Jöckel K-H, Bornfeld N, Lohmann D R
Department of Ophthalmology, University of Duisburg-Essen, Germany.
Eur J Cancer. 2005 Mar;41(5):735-40. doi: 10.1016/j.ejca.2004.12.022.
Patients with hereditary cancer are usually diagnosed earlier than patients with non-hereditary tumours. In children with isolated unilateral retinoblastoma, some of whom have a hereditary predisposition, this rule has been subject to debate. We have analysed the clinical manifestation of disease in 188 children with completely resolved mutational status. In 24 (13%) of these patients, testing of blood DNA showed a constitutional RB1 mutation. The distribution of age at diagnosis was not different between patients with and without a constitutional mutation. However, patients with loss of the maternally inherited RB1 allele had an earlier age at diagnosis than patients with loss of the paternally inherited RB1 allele. Our data show that early age at diagnosis does not identify patients with isolated unilateral retinoblastoma that have a higher risk of being carriers of a RB1 gene mutation. Our findings suggest that, at least in some patients, age at diagnosis is modified by a parent-of-origin effect.
遗传性癌症患者的诊断通常比非遗传性肿瘤患者更早。在患有孤立性单侧视网膜母细胞瘤的儿童中,其中一些具有遗传易感性,这一规则一直存在争议。我们分析了188例突变状态已完全明确的儿童疾病的临床表现。在这些患者中,24例(13%)的血液DNA检测显示存在RB1基因的胚系突变。有或没有胚系突变的患者之间诊断年龄的分布没有差异。然而,母系遗传的RB1等位基因缺失的患者比父系遗传的RB1等位基因缺失的患者诊断年龄更早。我们的数据表明,诊断年龄早并不能识别出患有孤立性单侧视网膜母细胞瘤且携带RB1基因突变风险更高的患者。我们的研究结果表明,至少在一些患者中,诊断年龄受到亲本来源效应的影响。